DavidP.BleichMD
Endocrinology • Newark, NJDiabetes, Lipid Metabolism
Professor, Medicine, Rutgers New Jersey Medical School/Chief, Division of Endocrinology, Diabetes, & Metabolism
Dr. Bleich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
185 South Orange Avenue, MSB I-588
Newark, NJ 07103Phone+1 973-972-6170Fax+1 973-972-5185
Summary
- I have chaired many committees and have been Division chief for 16 years. I am interested in impacting on healthcare at a higher level. Full Professor of Medicine with business acumen, negotiating skills, and thoughtful leadership. See my book The Diabetes LIFEMAP: Data-driven Diabetes Care for the 21st Century. Morgan James Publishing. 2020.
Education & Training
Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
Maimonides Medical CenterResidency, Internal Medicine, 1983 - 1986
New York Medical CollegeClass of 1983
Haverford CollegeBA, Chemistry, 1975 - 1979
Certifications & Licensure
CA State Medical License 1992 - Present
NJ State Medical License 2004 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2012-2019
- Inside Jersey Magazine Top Doctors Castle Connolly, 2012-2018
Clinical Trials
- Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease Start of enrollment: 2015 Sep 17
Publications & Presentations
PubMed
- 131 citationsResistance to type 1 diabetes induction in 12-lipoxygenase knockout miceDavid Bleich, Songyuan Chen, Brian Zipser, Duxin Sun, Colin D. Funk
The Journal of Clinical Investigation. 1999-05-15 - 89 citationsTissue Inhibitor of Metalloproteinase-1 Prevents Cytokine-Mediated Dysfunction and Cytotoxicity in Pancreatic Islets and β-cellsXiao Han, Yujie Sun, Stephen Scott, David Bleich
Diabetes. 2001-05-01 - 87 citationsSystemic impact of intestinal helminth infections.Pankaj K. Mishra, Mark Palma, David Bleich, P'ng Loke, William C. Gause
Mucosal Immunology. 2014-04-16
Journal Articles
- Challenges to Reshape the Future of Type 1 Diabetes ResearchDavid Bleich, MD, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
New Research Links Taking Vitamin D to Better Cardiometabolic Health, but Doctors Have Some NotesOctober 8th, 2024
Challenges Remain That Prevent Optimal Type 1 Diabetes Research and Clinical TrialsOctober 3rd, 2018
More Evidence Adding Nuts Is a Healthy ChoiceApril 26th, 2013
Professional Memberships
- Member
- Member
- Endocrine SocietyMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
